ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,433.74
0.23%
Dow Jones
38,647.10
0.00%
US Dollar vs MXN
18.5863
0.89%
Brent Oil
83.03
1.29%
Bitcoin
67,054.81
0.45%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
14/06/202406:48PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NEWS
14/06/202406:46PR Newswire (Canada)George Weston Limitée conclut un plan d'achat d'actions automatiqueTSX:WNGeorge Weston Ltd
14/06/202406:45PR Newswire (Canada)NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE INVESTMENT TRUST ANNOUNCES JUNE 2024 DISTRIBUTIONTSX:NWH.UNNorthwest Healthcare Properties Real Estate Investment Trust
14/06/202406:45PR Newswire (US)Consumer and Industry Advocates Highlight Measures to Counter Rise in Elder Real Estate Fraud and Financial Exploitation
14/06/202406:45PR Newswire (Canada)Decisive Dividend Corporation Announces July 2024 DividendTSXV:DEDecisive Dividend Corporation
14/06/202406:45PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - NEWS
14/06/202406:42PR Newswire (Canada)George Weston Limited Enters into Automatic Share Purchase PlanTSX:WNGeorge Weston Ltd
14/06/202406:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
14/06/202406:40Business WireFuture Technologies Continues Energy Market Development with West Texas Office Expansion and Technology Showcase
14/06/202406:35Business WireEl programa de pruebas del Cessna Citation Ascend sigue adelante con el exitoso segundo artículo de prueba de vueloNYSE:TXTTextron Inc
14/06/202406:34PR Newswire (US)Roy Jorgensen Associates, Inc. Receives Toyota Supplier of the Year Award
14/06/202406:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ITGRInteger Holdings Corporation
14/06/202406:32CointelegraphBitcoin breaks 18-month hashrate uptrend. Are BTC miners capitulating?COIN:BTCUSDBitcoin
14/06/202406:30GlobeNewswire Inc.Plato Gold Welcomes Mr. Ernie J. Marcotte to the Board of DirectorsTSXV:PGCPlato Gold Corp
14/06/202406:30GlobeNewswire Inc.Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 CongressNASDAQ:IRONDisc Medicine Inc
14/06/202406:30GlobeNewswire Inc.Intellia Therapeutics Names Brian Goff to its Board of DirectorsNASDAQ:NTLAIntellia Therapeutics Inc
14/06/202406:30GlobeNewswire Inc.JOYY Inc. Announces the Results of the Repurchase Right Offer for its 1.375% Convertible Senior Notes due 2026NASDAQ:YYJOYY Inc
14/06/202406:30GlobeNewswire Inc.Phase 2 Findings Show Wugen’s Investigational Allogeneic CAR-T, WU-CART-007, Was Highly Effective and Surpassed Standard of Care in Treating Hard-to-Treat T-ALL/LBL; Data Presented Today at European Hematology Association (EHA) 2024 Hybrid Congress
14/06/202406:30GlobeNewswire Inc.Auction result of Treasury Bills - RIKV 24 0821 - RIKV 24 1218
14/06/202406:30GlobeNewswire Inc.Brixton Metals Appoints Patrick Highsmith to its Board of DirectorsTSXV:BBBBrixton Metals Corporation
14/06/202406:30GlobeNewswire Inc.Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evaluating Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)NASDAQ:COGTCogent Biosciences Inc
14/06/202406:30PR Newswire (Canada)Un chef canadien triomphe à la Coupe internationale des chefs Aramark 2024, à TorontoNYSE:ARMKAramark
14/06/202406:30PR Newswire (Canada)Canadian Chef Triumphs at Aramark International Chefs' Cup 2024 in TorontoNYSE:ARMKAramark
14/06/202406:30PR Newswire (US)Nucor Announces Guidance for the Second Quarter of 2024 EarningsNYSE:NUENucor Corporation
14/06/202406:30PR Newswire (US)A Comparison of Vaccine Technologies to be Presented at the ASM Microbe ConferenceNASDAQ:SNGXSoligenix Inc
14/06/202406:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
14/06/202406:24Alliance NewsAlliance NewsCorero Network Security wins three-year partnership with A2 HostingLSE:CNSCorero Network Security Plc
14/06/202406:24PR Newswire (US)Banded tuition plan offers 15 credits for price of 12 at Governors State
14/06/202406:21IH Market NewsAdobe Soars 15% Pre-Market; Visa and Mastercard Encounter Hurdles in $30 Billion Agreement, and MoreNYSE:WFCWells Fargo and Company
14/06/202406:20Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RWODWRedwoods Acquisition Corporation

Su Consulta Reciente

EU
SGFT
Societe Generale 3.207% ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados